Invention Grant
- Patent Title: Modified cascade ribonucleoproteins and uses thereof
-
Application No.: US17179215Application Date: 2021-02-18
-
Publication No.: US11939604B2Publication Date: 2024-03-26
- Inventor: Stan Johan Jozef Brouns , John van der Oost
- Applicant: Caribou Biosciences, Inc.
- Applicant Address: US CA Berkeley
- Assignee: Caribou Biosciences, Inc.
- Current Assignee: Caribou Biosciences, Inc.
- Current Assignee Address: US CA Berkeley
- Agent Barbara G. McClung; Olga Zimmerman
- Priority: GB 22458 2011.12.30
- Main IPC: C12N9/22
- IPC: C12N9/22 ; A61K48/00 ; C07K14/245 ; C07K14/47 ; C12N9/16 ; C12N15/62 ; C12N15/66 ; C12N15/70 ; C12N15/74 ; C12N15/81 ; C12N15/82 ; C12N15/86 ; C12N15/90 ; A61K38/00

Abstract:
A clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for adaptive antiviral defence (Cascade); the Cascade protein complex comprising at least CRISPR-associated protein subunits Cas7, Cas5 and Cash which includes at least one subunit with an additional amino acid sequence possessing nucleic acid or chromatin modifying, visualising, transcription activating or transcription repressing activity. The Cascade complex with additional activity is combined with an RNA molecule to produce a ribonucleoprotein complex. The RNA molecule is selected to have substantial complementarity to a target sequence. Targeted ribonucleoproteins can be used as genetic engineering tools for precise cutting of nucleic acids in homologous recombination, non-homologous end joining, gene modification, gene integration, mutation repair or for their visualisation, transcriptional activation or repression. A pair of ribonucleotides fused to FokI dimers may be used to generate double-strand breakages in the DNA to facilitate these applications in a sequence-specific manner.
Public/Granted literature
- US20210171926A1 MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF Public/Granted day:2021-06-10
Information query